As of November 26, 2024, fosun hi-tech holds approximately 35.99% of the shares of fosun pharma, of which part of the A-shares have been released from pledge. The number of shares released from pledge is 0.12 billion shares, accounting for 12.48% of the shares held, and 4.49% of the total shares of the company. After the release, fosun hi-tech has 0.5338 billion shares remaining pledged, accounting for 55.52% of the shares it holds. Fosun hi-tech and its concerted actors hold approximately 36.23% of the shares of fosun pharma in total. After the release from pledge, the remaining pledged shares amount to 0.5338 billion shares, accounting for 55.16% of the shares they hold. Fosun hi-tech confirms that there may be plans for pledging in the future, and...Show More

As of November 26, 2024, fosun hi-tech holds approximately 35.99% of the shares of fosun pharma, of which part of the A-shares have been released from pledge. The number of shares released from pledge is 0.12 billion shares, accounting for 12.48% of the shares held, and 4.49% of the total shares of the company. After the release, fosun hi-tech has 0.5338 billion shares remaining pledged, accounting for 55.52% of the shares it holds. Fosun hi-tech and its concerted actors hold approximately 36.23% of the shares of fosun pharma in total. After the release from pledge, the remaining pledged shares amount to 0.5338 billion shares, accounting for 55.16% of the shares they hold. Fosun hi-tech confirms that there may be plans for pledging in the future, and it will fulfill the obligation to inform according to the actual circumstances and legal requirements. The company will disclose relevant information in a timely manner as required. This announcement was released by the board of directors of fosun pharma on November 27, 2024. Chairman Wu Yifang confirmed the authenticity, accuracy, and completeness of the announcement on behalf of the company and assumes legal responsibility.